Gordon J. Freeman

Cancer researcher Gordon J. Freeman works in the Department of Medical Oncology at Dana-Farber Cancer Institute and is professor of medicine at Harvard Medical School. Freeman’s research led directly to the development of a successful strategy for cancer immunotherapy: block the pathways that tumors use to turn off the immune response.

Freeman has published over 300 scientific papers and holds over 50 US patents on immunotherapies. He received the 2014 William B. Coley Award for Distinguished Research in Tumor Immunology and the 2017 Warren Alpert Foundation award for this work, which led to development of the PD-1 pathway blockade for cancer immunotherapy.

Freeman earned his B.A. in biochemistry and molecular biology and his Ph.D. in microbiology and molecular genetics from Harvard University.